lung cancer

Chapter 27: Cancer of the Lung

Etiology

  • Leading Cause of Cancer Deaths: Lung cancer is recognized as the leading cause of cancer-related deaths in the United States.

  • Annual Incidence: More than 228,190 new cases reported annually in the United States, broken down by gender:

    • Approximately 118,080 cases in males.

    • Approximately 110,110 cases in females.

Anatomic Alterations of the Lungs

  • Various anatomic changes associated with lung cancer include:

    • Inflammation, swelling, and destruction of bronchial airways and alveoli.

    • Excessive mucus production leading to tracheobronchial mucus accumulation and airway obstruction.

    • Tumors can project into a bronchus causing blockage.

    • Potential consequences include:

    • Atelectasis (collapse of lung tissue).

    • Alveolar consolidation (fluid in the alveoli).

    • Cavity formation in lung tissues.

    • Pleural effusion (fluid accumulation in the pleural space).

Types of Cancer

  • Non-Small-Cell Lung Cancer (NSCLC): Composed of:

    • Squamous cell carcinoma.

    • Adenocarcinoma.

    • Large-cell carcinoma (Undifferentiated).

  • Small-Cell Lung Cancer (SCLC): Also known as small-cell or oat cell carcinoma.

Characteristics of Lung Cancers

  • Table 26-1 summarizes the characteristics of lung cancers:

    • Squamous Cell Carcinoma:

    • Growth Rate: Slow

    • Metastasis: Late; primarily to hilar lymph nodes

    • Means of Diagnosis: Biopsy, sputum analysis, bronchoscopy, and electron microscopy.

    • Adenocarcinoma:

    • Growth Rate: Moderate

    • Metastasis: Early and widespread

    • Means of Diagnosis: Radiography, sputum analysis, bronchoscopy, and electron microscopy.

    • Large-Cell Carcinoma:

    • Growth Rate: Rapid

    • Metastasis: Early

    • Means of Diagnosis: Similar to adenocarcinoma.

    • Small-Cell (Oat Cell) Carcinoma:

    • Growth Rate: Very rapid

    • Metastasis: Very early; can spread to the mediastinum or distally in the lung.

Screening and Diagnosis

  • Common Screening Methods include:

    • Routine chest x-ray.

    • Computed tomography (CT) scan.

    • Positron emission tomography (PET) scan.

    • Tissue biopsy is definitive for diagnosis.

Procedures for Tissue Biopsy

  • Various procedures for obtaining tissue biopsy include:

    • Bronchoscopy.

    • Thoracoscopy.

    • Transbronchial needle biopsy.

    • Open-lung biopsy.

    • Sputum cytology.

    • Thoracentesis.

    • Video thoracoscopy.

Staging of Lung Cancer

  • Staging Process: Classification based on several factors:

    • Type of cancer.

    • Size of the tumor.

    • Level of lymph node involvement.

    • Extent of cancer spread.

    • Important for evaluating prognosis and treatment options.

TNM Classification System
  • Components of Staging:

    • T: Extent of the primary tumor.

    • N: Lymph node involvement.

    • M: Extent of metastasis.

  • Use of Roman numerals (I to IV) to designate stages with 0 being the least advanced and IV the most.

Definitions of Staging Symbols
  • Primary Tumor (T):

    • T0: No evidence of tumor.

    • Tx: Tumor that cannot be assessed.

  • Lymph Nodes (N):

    • Nx: Regional lymph nodes cannot be assessed.

    • N0: Absence of regional lymph involvement.

  • Distant Metastasis (M):

    • Mx: Metastasis cannot be assessed.

    • M0: Absence of distant metastasis.

Stage Classifications
  • Stage I: T1 (with or without nodal involvement).

  • Stage II: More advanced tumors (T2N1).

  • Stage III: Includes advanced involvement (T2N2).

  • Stage IV: Most advanced with distant spread.

Staging of Non-Small-Cell Cancer

  • Subcategories of Staging:

    • Stage 0.

    • Stage I.

    • Stage II.

    • Stage III A.

    • Stage III B.

    • Stage IV.

Staging of Small-Cell Cancer

  • Classified into two categories:

    • Limited: Confined to one lung and neighboring lymph nodes.

    • Extensive: Spread beyond one lung and neighboring lymph nodes, potentially to both lungs or other organs.

Clinical Manifestations

  • Common Symptoms:

    • Atelectasis.

    • Alveolar consolidation.

    • Excessive bronchial secretions.

Clinical Data at Patient’s Bedside

  • Physical Examination Findings:

    • Vital Signs:

    • Increased respiratory rate (tachypnea).

    • Increased heart rate (pulse).

    • Potential changes in blood pressure.

    • Cyanosis: Indicating low oxygen saturation.

    • Cough, Sputum Production, Hemoptysis (coughing blood).

    • Chest Assessment Findings:

    • Presence of crackles, rhonchi, wheezing.

Pulmonary Function Testing (PFT)

  • The results may vary based on tumor origin and may indicate:

    • Obstructive Values: When malignancy obstructs major airways (especially with COPD).

    • Restrictive Values: When large areas of lung tissue are affected, for example, in extensive bronchioalveolar carcinoma.

Hemodynamics

  • Changes that may occur in relation to hypoxemia and acidosis due to tumor interaction with mediastinal structures:

    • Central Venous Pressure (CVP): Increased.

    • Pulmonary Artery (PA) Pressure: Decreased.

    • Pulmonary Capillary Wedge Pressure (PCWP): Normal or decreased.

    • Cardiac Output (CO): May be decreased or normal.

Chest Radiograph Findings

  • Potential Indicators:

    • Small oval or coin-like lesion.

    • Large irregular masses.

    • Alveolar consolidation.

    • Atelectasis.

    • Pleural effusion.

    • Mediastinal or diaphragmatic involvement.

Imaging Findings

  • Figure References:

    • Illustrations depict various abnormalities including squamous cell carcinoma, suspicious nodules, and confirmed malignant nodules highlighting the importance of diagnostic imaging in lung cancer detection.

Common Non-Respiratory Manifestations

  • Symptoms Indicating Miscellaneous Issues:

    • Hoarseness.

    • Difficulty swallowing.

    • Superior vena cava syndrome.

    • General weakness and neck and facial edema.

    • Electrolyte abnormalities.

General Management of Lung Cancer

  • Treatment Modalities:

    • Surgery: Various procedures depending on tumor staging, including:

    • Wedge resection.

    • Segmentectomy.

    • Lobectomy.

    • Bilobectomy.

    • Pneumonectomy.

    • Chemotherapy: Involves chemical agents targeting malignant cells.

    • Radiation Therapy: Often given palliatively or curatively when surgery is not an option.

Comfort and Supportive Care

  • In cases of extensive small-cell lung cancer in deteriorating health:

    • Emphasis on comfort and palliative care rather than aggressive treatment.

Therapist Driven Protocols

  • Therapeutic approaches include:

    • Oxygen Therapy Protocol.

    • Bronchopulmonary Hygiene Therapy Protocol.

    • Lung Expansion Therapy Protocol.

    • Aerosolized Medication.